Codex DNA Inc (DNAY)

6.80 +0.06  +0.89% NASDAQ Nov 26, 16:00 USD

Codex DNA Return on Equity

View 4,000+ financial data types
Browse...

Historical Return on Equity Data

View and export this data going back to 2021. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 Upgrade
   
June 30, 2021 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View Return on Equity for DNAY

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

Advertisement

Return on Equity (ROE) Definition

Return on Equity measures Net Income / Average Shareholder's Equity. This metric is important because it gives an idea of how efficiently a business is being run. ROE can vary for different sectors and industries depending on the financial statement structures.

Read full definition.

Return on Equity Range, Past 5 Years

Minimum Upgrade Jun 2021
Maximum Upgrade Sep 2021
Average Upgrade

News

Codex DNA acquires Eton Bioscience for ~$13M
SA Breaking News 11/10 06:17 ET
Codex DNA Acquires Eton Bioscience
Globe Newswire 11/09 16:15 ET
--Cowen Starts Codex DNA at Outperform
MT Newswires 07/13 06:53 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.